Matches in Wikidata for { <http://www.wikidata.org/entity/Q94509343> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q94509343 description "article scientifique publié en 2020" @default.
- Q94509343 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94509343 description "scientific article published on 04 May 2020" @default.
- Q94509343 description "wetenschappelijk artikel" @default.
- Q94509343 description "наукова стаття, опублікована 4 травня 2020" @default.
- Q94509343 name "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 name "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 type Item @default.
- Q94509343 label "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 label "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 prefLabel "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 prefLabel "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 P1433 Q94509343-DBC8722C-254D-4A65-9081-3594E7F5772F @default.
- Q94509343 P1476 Q94509343-6E0BB06A-D445-4509-B7F5-AA6604806986 @default.
- Q94509343 P2093 Q94509343-83EF36B3-AC29-444E-9663-D69D93A1D293 @default.
- Q94509343 P2093 Q94509343-98D55190-5F2A-41EC-8334-B87827BC8D4B @default.
- Q94509343 P2093 Q94509343-AF548B6B-07E0-4F42-913F-BA05AD2F91EE @default.
- Q94509343 P2093 Q94509343-BB1570CB-94D7-415A-A757-C0F744392826 @default.
- Q94509343 P2093 Q94509343-C33FDA22-3E76-4CBB-8EC8-785BF6B0EE61 @default.
- Q94509343 P2093 Q94509343-F0605B47-DBFA-452E-9FB5-C56E0BFA2200 @default.
- Q94509343 P31 Q94509343-0B4F233A-09FF-456C-B54F-9758694EEA4D @default.
- Q94509343 P356 Q94509343-B98BD929-B500-49AD-9ADF-AD0A4B2CAA3C @default.
- Q94509343 P577 Q94509343-2F68A80F-F977-4D43-9F0B-3C8BE848C70A @default.
- Q94509343 P698 Q94509343-B60F136A-66E4-4E66-8091-363E3A04DDF5 @default.
- Q94509343 P921 Q94509343-3A506C2F-3B8F-45D6-AFF0-D71B2370AA0E @default.
- Q94509343 P921 Q94509343-EFD27FAD-53E0-4221-B410-437ED2A459C7 @default.
- Q94509343 P932 Q94509343-DC20BF06-F25A-4D59-8879-3CB82C6A7D8F @default.
- Q94509343 P356 JAMANEUROL.2020.0851 @default.
- Q94509343 P698 32364568 @default.
- Q94509343 P1433 Q276813 @default.
- Q94509343 P1476 "Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis" @default.
- Q94509343 P2093 "Ann Eriksson-Dufva" @default.
- Q94509343 P2093 "Fredrik Piehl" @default.
- Q94509343 P2093 "Max Albert Hietala" @default.
- Q94509343 P2093 "Rayomand Press" @default.
- Q94509343 P2093 "Susanna Brauner" @default.
- Q94509343 P2093 "Thomas Frisell" @default.
- Q94509343 P31 Q13442814 @default.
- Q94509343 P356 "10.1001/JAMANEUROL.2020.0851" @default.
- Q94509343 P577 "2020-05-04T00:00:00Z" @default.
- Q94509343 P698 "32364568" @default.
- Q94509343 P921 Q412323 @default.
- Q94509343 P921 Q8285 @default.
- Q94509343 P932 "7199182" @default.